Trial Profile
Randomized Double Blind Placebo Controlled Trial of Barrett's Esophagus Chemoprevention With Metformin.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Metformin (Primary)
- Indications Oesophageal cancer
- Focus Therapeutic Use
- 11 Apr 2013 Planned end date changed from 1 Jun 2012 to 1 Jun 2013 as reported by ClinicalTrials.gov.
- 11 Apr 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 25 Mar 2012 New source identified and integrated (Mayo Clinic).